Clinical Trial Update: Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating the efficacy and safety of topical SHR0302 ointment for mild-to-moderate atopic dermatitis across Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SHR0302 ointment

Snippet

Sponsor: Reistone Biopharma Company Limited | Conditions: Atopic Dermatitis | Phase 2, Phase 3 | Status: UNKNOWN